October 21, 2016 3:16 PM ET


Company Overview of ACCU-BREAK Pharmaceuticals, Inc.

Executive Profile

Elliot F. Hahn Ph.D.

Executive Chairman of the Board, ACCU-BREAK Pharmaceuticals, Inc.
AgeTotal Calculated CompensationThis person is connected to 6 Board Members in 6 different organizations across 9 different industries.

See Board Relationships


Dr. Elliot F. Hahn, Ph.D. serves as the Chairman and Chief Executive Officer of SoLapharm, Inc. Dr. Hahn serves as President of Andrx Laboratories Inc. He served as President of ACCU-BREAK Pharmaceuticals, Inc. (ABP) from October 2004 to December 2007 and Chairman from January 2008 to March 2009. He co-founded Andrx Corporation and served as its President from February 1993 to March 2003 and its Chief Executive Officer from October 2001 to June 2002. Dr. Hahn served ...

Corporate Headquarters

1000 South Pine Island Road
Plantation, Florida 33324

United States

Phone: 954-236-7351
Fax: 954-236-7271

Board Members Memberships

Director, Chairman of Governance & Nominating Committee, Chairman of Compensation Committee and Member of Audit Committee
Executive Chairman of the Board
Director and Member of Nominating & Corporate Governance Committee
Director and Member of Compensation Committee


Cornell University
The City College of New York

Other Affiliations

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

There is no Stock Options data available.

Total Compensation

There is no Total Compensation data available.

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup


There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact ACCU-BREAK Pharmaceuticals, Inc., please visit . Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.